FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029168579> ?p ?o ?g. }

• W2029168579 endingPage "429" @default.
• W2029168579 startingPage "423" @default.
• W2029168579 abstract "Antisense oligonucleotides were used to determine the role of the BCR-ABL gene in the proliferation of chronic myeloid leukaemia (CML) clonogenic cells. Peripheral blood Philadelphia chromosome positive cells were obtained from eight CML patients at diagnosis (chronic phase = 7; accelerated phase = 1). Mononuclear cells were incubated with synthetic antisense 18-mer oligonucleotides complementary to the two different junctions b2a2 or b3a2. The type of junction (b2a2 or b3a2) was previously determined by RT-PCR techniques. Cells incubated for 12 to 14 hours with or without sense oligonucleotides served as controls. After incubation with oligonucleotides, the cell DNA synthesis was analysed by flow cytometry using the BrdUrd/DNA method and the cell plating efficiency in methylcellulose was determined. In six of the seven patients in chronic phase, there was a significant inhibition of CFU-GM production which was only 68.4 +/- 19%; (p < .01) of that found in controls. The S phase index, which depends upon the percentage of S phase cells as well as the fluorescence intensity, was 48 +/- 29% (p < .01) of the control values for the seven patients in chronic phase. Interestingly, for the only CML patient in accelerated phase, antisense oligomers had no inhibitory effect on either the production of CFU-GM or the number of S phase cells. In improving the specificity of oligomers, it might be useful for gene-targeted anti-leukemic therapy and/or bone marrow purging." @default.
• W2029168579 created "2016-06-24" @default.
• W2029168579 creator A5011977231 @default.
• W2029168579 creator A5013255815 @default.
• W2029168579 creator A5017580969 @default.
• W2029168579 creator A5022153341 @default.
• W2029168579 creator A5032477884 @default.
• W2029168579 creator A5041817169 @default.
• W2029168579 creator A5051192400 @default.
• W2029168579 creator A5053145345 @default.
• W2029168579 creator A5065712165 @default.
• W2029168579 creator A5082556359 @default.
• W2029168579 date "1995-01-01" @default.
• W2029168579 modified "2023-10-17" @default.
• W2029168579 title "Specific Antisense Oligomer Anti Bcr-abl Junctions in Chronic Myeloid Leukemia: A Cell Cycle Analysis and CFU-GM Study" @default.
• W2029168579 cites W19160273 @default.
• W2029168579 cites W1971535749 @default.
• W2029168579 cites W1998919839 @default.
• W2029168579 cites W2000104606 @default.
• W2029168579 cites W2020092689 @default.
• W2029168579 cites W2040396943 @default.
• W2029168579 cites W2049926026 @default.
• W2029168579 cites W2050642909 @default.
• W2029168579 cites W2051352904 @default.
• W2029168579 cites W2071068176 @default.
• W2029168579 cites W2071808385 @default.
• W2029168579 cites W2076372887 @default.
• W2029168579 cites W2081638226 @default.
• W2029168579 cites W2085232109 @default.
• W2029168579 cites W2089483984 @default.
• W2029168579 cites W2093308293 @default.
• W2029168579 cites W2106143300 @default.
• W2029168579 cites W2127546252 @default.
• W2029168579 cites W2162258100 @default.
• W2029168579 cites W2386721483 @default.
• W2029168579 cites W4242979458 @default.
• W2029168579 doi "https://doi.org/10.3109/10428199509112200" @default.
• W2029168579 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8590842" @default.
• W2029168579 hasPublicationYear "1995" @default.
• W2029168579 type Work @default.
• W2029168579 sameAs 2029168579 @default.
• W2029168579 citedByCount "4" @default.
• W2029168579 crossrefType "journal-article" @default.
• W2029168579 hasAuthorship W2029168579A5011977231 @default.
• W2029168579 hasAuthorship W2029168579A5013255815 @default.
• W2029168579 hasAuthorship W2029168579A5017580969 @default.
• W2029168579 hasAuthorship W2029168579A5022153341 @default.
• W2029168579 hasAuthorship W2029168579A5032477884 @default.
• W2029168579 hasAuthorship W2029168579A5041817169 @default.
• W2029168579 hasAuthorship W2029168579A5051192400 @default.
• W2029168579 hasAuthorship W2029168579A5053145345 @default.
• W2029168579 hasAuthorship W2029168579A5065712165 @default.
• W2029168579 hasAuthorship W2029168579A5082556359 @default.
• W2029168579 hasConcept C104317684 @default.
• W2029168579 hasConcept C117262875 @default.
• W2029168579 hasConcept C125418893 @default.
• W2029168579 hasConcept C129312508 @default.
• W2029168579 hasConcept C137061746 @default.
• W2029168579 hasConcept C138626823 @default.
• W2029168579 hasConcept C143141573 @default.
• W2029168579 hasConcept C147789679 @default.
• W2029168579 hasConcept C1491633281 @default.
• W2029168579 hasConcept C153911025 @default.
• W2029168579 hasConcept C185592680 @default.
• W2029168579 hasConcept C201750760 @default.
• W2029168579 hasConcept C202751555 @default.
• W2029168579 hasConcept C2778729363 @default.
• W2029168579 hasConcept C2778904597 @default.
• W2029168579 hasConcept C2779282312 @default.
• W2029168579 hasConcept C28328180 @default.
• W2029168579 hasConcept C29537977 @default.
• W2029168579 hasConcept C42362537 @default.
• W2029168579 hasConcept C502942594 @default.
• W2029168579 hasConcept C552990157 @default.
• W2029168579 hasConcept C553184892 @default.
• W2029168579 hasConcept C55493867 @default.
• W2029168579 hasConcept C62478195 @default.
• W2029168579 hasConcept C86803240 @default.
• W2029168579 hasConcept C95444343 @default.
• W2029168579 hasConceptScore W2029168579C104317684 @default.
• W2029168579 hasConceptScore W2029168579C117262875 @default.
• W2029168579 hasConceptScore W2029168579C125418893 @default.
• W2029168579 hasConceptScore W2029168579C129312508 @default.
• W2029168579 hasConceptScore W2029168579C137061746 @default.
• W2029168579 hasConceptScore W2029168579C138626823 @default.
• W2029168579 hasConceptScore W2029168579C143141573 @default.
• W2029168579 hasConceptScore W2029168579C147789679 @default.
• W2029168579 hasConceptScore W2029168579C1491633281 @default.
• W2029168579 hasConceptScore W2029168579C153911025 @default.
• W2029168579 hasConceptScore W2029168579C185592680 @default.
• W2029168579 hasConceptScore W2029168579C201750760 @default.
• W2029168579 hasConceptScore W2029168579C202751555 @default.
• W2029168579 hasConceptScore W2029168579C2778729363 @default.
• W2029168579 hasConceptScore W2029168579C2778904597 @default.
• W2029168579 hasConceptScore W2029168579C2779282312 @default.
• W2029168579 hasConceptScore W2029168579C28328180 @default.
• W2029168579 hasConceptScore W2029168579C29537977 @default.
• W2029168579 hasConceptScore W2029168579C42362537 @default.

• next